Biotech firms urge authorization of follow-on biologics

02/18/2008 | News & Observer (Raleigh, N.C.), The

The biotech industry is pushing lawmakers to pass a law this year that allows follow-on biologics to be sold on the U.S. market, before the 2008 elections are expected to overshadow issues that include the sector's interests. "We've made good progress in having this issue understood by the people who are in place on Capitol Hill now. ... And we'd like to get it done this year so we don't have to start all over again," BIO President Jim Greenwood said.

View Full Article in:

News & Observer (Raleigh, N.C.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA